A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma
Colin M. Court, Shuang Hou, Paul Winograd, Nicholas H. Segel, Qingyu Wilda Li, Yazhen Zhu, Saeed Sadeghi, Richard S. Finn, Ekambaram Ganapathy, Min Song, Samuel W. French, Bita V. Naini, Shonan Sho, Fady M. Kaldas, Ronald W. Busuttil, James S. Tomlinson, Hsian‐Rong Tseng, Vatche G. Agopian – 6 April 2018 – Current clinicopathologic staging systems and serum biomarkers poorly discriminate tumor biology in hepatocellular carcinoma (HCC), with high recurrence rates following curative‐intent surgical resection and liver transplantation (LT).